# Dr. Reddy's Laboratories Limited CTO VI - Inspection Records

Source: https://www.keypedia.com/companies/dr-reddys-laboratories-limited-cto-vi/b0843338-2d7a-4525-9e2d-8a9ab428db2f

> Inspection records and compliance data for Dr. Reddy's Laboratories Limited CTO VI in Srikakulam, None. Access full analysis and detailed observations.

---

## Details

- Name: Dr. Reddy's Laboratories Limited CTO VI
- FEI Number: 3002949085
- City: Srikakulam
- State: None
- Country Name: India
- Address Line 1: APIIC Industrial Estate, Pydibhimavaram, Ranasthalam Mandal
- Zip Code: None
- Facility Type: API Manufacturer
- Business Operations: API MANUFACTURE, API/FDF ANALYTICAL TESTING, PACK

## Related Documents

- [483 - Dr. Reddy's Laboratories Limited CTO VI - 2024-06-07](https://www.keypedia.com/records/483/dr-reddys-laboratories-limited-cto-vi/0f8e7b96-e996-493f-abbe-c0625f1f10e5) — source: FDA, date: June 7, 2024
- [483 - Dr. Reddy's Laboratories Limited CTO VI - 2024-06-07](https://www.keypedia.com/records/483/dr-reddys-laboratories-limited-cto-vi/b2260347-a826-4850-b75a-2bba503efa5e) — source: FDA, date: June 7, 2024
- [FDA Inspection 1240650 - Dr. Reddy's Laboratories Limited CTO VI - 2024-06-07](https://www.keypedia.com/records/fda_inspections/dr-reddys-laboratories-limited-cto-vi/f633191d-3932-4c5a-be17-7227a027f3cb) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 7, 2024
- [FDA Inspection 1219323 - Dr. Reddy's Laboratories Limited CTO VI - 2023-07-19](https://www.keypedia.com/records/fda_inspections/dr-reddys-laboratories-limited-cto-vi/d8c03c1d-1091-453a-8d2d-31734dee83f6) — classification: No Action Indicated (NAI), source: FDA, date: July 19, 2023
- [483 - Dr. Reddy's Laboratories Limited CTO VI - 2020-01-28](https://www.keypedia.com/records/483/dr-reddys-laboratories-limited-cto-vi/8db56378-b1e2-4dea-a0e9-1546693fd707) — source: FDA, date: January 28, 2020
- [483 - Dr. Reddy's Laboratories Limited CTO VI - 2020-01-28](https://www.keypedia.com/records/483/dr-reddys-laboratories-limited-cto-vi/0d54e5f3-cfc5-4971-9157-f4d33117aed3) — source: FDA, date: January 28, 2020
- [FDA Inspection 1120671 - Dr. Reddy's Laboratories Limited CTO VI - 2020-01-28](https://www.keypedia.com/records/fda_inspections/dr-reddys-laboratories-limited-cto-vi/69941f75-7de7-479a-bf3b-2662f35afd9c) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 28, 2020
- [483 - Dr. Reddy's Laboratories Limited CTO VI - 2017-04-04](https://www.keypedia.com/records/483/dr-reddys-laboratories-limited-cto-vi/4d5d51a6-6eff-4351-858d-1331f95a4314) — source: FDA, date: April 4, 2017
- [FDA Inspection 1011964 - Dr. Reddy's Laboratories Limited CTO VI - 2017-04-04](https://www.keypedia.com/records/fda_inspections/dr-reddys-laboratories-limited-cto-vi/bee5e999-3417-4d33-ad03-8225f7085046) — classification: Official Action Indicated (OAI), source: FDA, date: April 4, 2017
- [FDA Inspection 904933 - Dr. Reddy's Laboratories Limited CTO VI - 2014-11-21](https://www.keypedia.com/records/fda_inspections/dr-reddys-laboratories-limited-cto-vi/bab5f0a6-9087-4477-b650-3525b88abcda) — classification: Official Action Indicated (OAI), source: FDA, date: November 21, 2014
- [483 - Dr. Reddy's Laboratories Limited CTO VI - 2014-11-17](https://www.keypedia.com/records/483/dr-reddys-laboratories-limited-cto-vi/d171cc2f-d87c-49c9-b22a-bcb851894db0) — source: FDA, date: November 17, 2014
- [FDA Inspection 751812 - Dr. Reddy's Laboratories Limited CTO VI - 2011-09-23](https://www.keypedia.com/records/fda_inspections/dr-reddys-laboratories-limited-cto-vi/101f8d97-5cb2-4a4c-81c8-13b91c768156) — classification: No Action Indicated (NAI), source: FDA, date: September 23, 2011

## Related Companies

- [Chemeca Drugs Private Limited](https://www.keypedia.com/companies/chemeca-drugs-private-limited/34e19502-dfc5-4e8d-9f16-4e0969be6c29)
- [OMRIX Biopharmaceuticals Ltd](https://www.keypedia.com/companies/omrix-biopharmaceuticals-ltd/4dba4088-aab7-4db5-b1ac-169d2ba865ea)
- [CONCORD BIOTECH LIMITED](https://www.keypedia.com/companies/concord-biotech-limited/c9a73c1a-4592-4fb5-a677-4836e422fd62)
- [Torrent Pharmaceuticals Limited](https://www.keypedia.com/companies/torrent-pharmaceuticals-limited/801e26ba-26ed-40ab-84c9-d4ee2e24e42e)
- [AstraZeneca Pharmaceuticals LP](https://www.keypedia.com/companies/astrazeneca-pharmaceuticals-lp/6f9abb75-9352-43df-b761-026089396fa3)
- [Symrise, S. de R.L de C.V.](https://www.keypedia.com/companies/symrise-s-de-rl-de-cv/d361030e-c885-43cc-8647-fb4b7807f26f)
- [Merck Life Science Technologies (Nantong) Co., Ltd.](https://www.keypedia.com/companies/merck-life-science-technologies-nantong-co-ltd/37493d9d-656d-4dc2-ab62-650cd0281a8d)
- [NorthStar Medical Radioisotopes, LLC](https://www.keypedia.com/companies/northstar-medical-radioisotopes-llc/2ae91764-ce9b-4c3f-949b-bce9a564ba89)
- [Sekisui Medical Co., Ltd.](https://www.keypedia.com/companies/sekisui-medical-co-ltd/4dfadeea-0d4e-4543-9dfe-d210f0a51125)
- [Elementis Specialties (India) Private Limited](https://www.keypedia.com/companies/elementis-specialties-india-private-limited/1c638e07-22cd-495f-a398-96269847dbf2)

## Related Officers

- [President](https://www.keypedia.com/people/peter-e-baker/c32eb848-de28-4725-80c9-ef8548d445bf)
- [USFDA/Director Division of International Drug Quality/CDER OC](https://www.keypedia.com/people/carmelo-rosa/cfc7c00c-9e11-485e-babe-f7726a7796a7)
- [Kenneth H. Williams](https://www.keypedia.com/people/kenneth-h-williams/20a225cd-a3d5-478f-ae04-2a8e119df8a6)
- [PreApproval Manager](https://www.keypedia.com/people/gayle-s-lawson/cd8061de-f089-408c-bbfc-c7c7a5635dd7)
- [Aditi S. Thakur](https://www.keypedia.com/people/aditi-s-thakur/1c810eb2-86b0-4cae-b51d-43f3fb276ade)
- [Dipesh K. Shah](https://www.keypedia.com/people/dipesh-k-shah/d4df4040-13d1-477b-8c21-4c8e5b3fc5b9)